Variant report
Variant | esv3383423 |
---|---|
Chromosome Location | chr5:91222396-91225694 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:91224612..91225895-chr5:91517942..91518899,6 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs376541532 | chr5:91222400-91222401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs568570266 | chr5:91222409-91222410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs143915286 | chr5:91222583-91222584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs557370129 | chr5:91222626-91222627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs59343330 | chr5:91222632-91222633 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs574457124 | chr5:91222635-91222636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs558441340 | chr5:91222636-91222637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571879614 | chr5:91222655-91222656 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561752788 | chr5:91222663-91222664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs79594453 | chr5:91222672-91222673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs185672370 | chr5:91222769-91222770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs34349278 | chr5:91222782-91222783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs150640174 | chr5:91222805-91222806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs543047572 | chr5:91222836-91222837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs562767247 | chr5:91223002-91223003 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs563248351 | chr5:91223014-91223015 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs190089160 | chr5:91223060-91223061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs376281255 | chr5:91223068-91223069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs560113521 | chr5:91223089-91223090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs73129582 | chr5:91223106-91223107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs77913706 | chr5:91223139-91223140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs77915074 | chr5:91223147-91223148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs35834658 | chr5:91223164-91223165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568455226 | chr5:91223192-91223193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs530985456 | chr5:91223231-91223232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550801972 | chr5:91223241-91223242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs570476309 | chr5:91223348-91223349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs201896281 | chr5:91223415-91223416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs149820251 | chr5:91223423-91223424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs76792426 | chr5:91223673-91223674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs558408305 | chr5:91223674-91223675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs182685944 | chr5:91223687-91223688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs534508155 | chr5:91223776-91223777 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs563709568 | chr5:91223778-91223779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs77266992 | chr5:91223808-91223809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547756062 | chr5:91223898-91223899 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs554795898 | chr5:91223939-91223940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs574549585 | chr5:91223952-91223953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187506084 | chr5:91223966-91223967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs543465843 | chr5:91223968-91223969 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs557109937 | chr5:91223971-91223972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs191089205 | chr5:91224029-91224030 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs183806676 | chr5:91224085-91224086 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs570761534 | chr5:91224086-91224087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560076262 | chr5:91224095-91224096 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs528837100 | chr5:91224120-91224121 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs189156924 | chr5:91224188-91224189 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs376862615 | chr5:91224349-91224350 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562265230 | chr5:91224368-91224369 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs531026408 | chr5:91224402-91224403 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Prostate cancer | 21965145 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 19592390 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:91211000-91237600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr5:91221600-91224000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr5:91224000-91225600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr5:91224200-91225200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr5:91224200-91225200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
6 | chr5:91224200-91225200 | Enhancers | Muscle Satellite Cultured Cells | -- |
7 | chr5:91224400-91225000 | Enhancers | NH-A | brain |
8 | chr5:91224400-91225000 | Enhancers | NHDF-Ad | bronchial |
9 | chr5:91224400-91225200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr5:91224400-91225200 | Enhancers | Osteobl | bone |
11 | chr5:91224600-91224800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
12 | chr5:91224600-91225800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
13 | chr5:91225000-91226200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr5:91225200-91227400 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr5:91225400-91225600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr5:91225400-91226000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |